» Articles » PMID: 35260152

Multimodal Stress Reduction and Lifestyle Modification Program for Patients with Ulcerative Colitis: a Qualitative Study

Overview
Publisher Biomed Central
Date 2022 Mar 9
PMID 35260152
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Over 2 million people in Europe are affected by ulcerative colitis, which often severely impacts the quality of life of those concerned. Among other factors, lifestyle and psychosocial factors seem to play an important role in pathogenesis and course of the disease and can be addressed as a complement to pharmacotherapy in comprehensive lifestyle modification programs.

Methods: This qualitative study as part of a mixed methods approach was carried out in the framework of a randomized controlled trial that examined the effect of a comprehensive lifestyle-modification-program (10-week-day clinic program) on quality of life in patients with ulcerative colitis. Qualitative interviews were conducted with 20 out of 47 patients of the intervention group after the program. The aim was to deepen, supplement, and expand the quantitative results of the trial, i.e. to examine individual perceptions of the intervention, including subjective changes and the extent to which elements of the program were integrated into everyday life. Qualitative content analysis techniques utilizing the software MAXQDA were used.

Results: Patients with ulcerative colitis in our sample often experienced multiple negative effects on different levels (physical, psychological, and social) and impaired quality of life because of their disease. They reported generally positively about the program itself, and emphasized perceived positive changes regarding their psychological and physical well-being. The interviews indicated a good implementation of elements learned during the intervention in everyday life.

Conclusions: Through participation in a comprehensive lifestyle modification program in the structure of a day clinic complementary to pharmacotherapy, patients with ulcerative colitis can reduce psychosocial stress and physical symptoms and thereby actively improve their well-being and general quality of life. This patient-centered, holistic approach was rated as useful in countering the complex disease manifestation as well as meeting the individual needs of the patients regarding their disease.

Trial Registration: clinicaltrials.gov NCT02721823.

Citing Articles

Participants' perspectives on a multimodal stress management and comprehensive lifestyle modification program for patients with Crohn's disease-A qualitative interview study.

Schlee C, Uecker C, Oznur O, Bauer N, Langhorst J PLoS One. 2024; 19(11):e0313127.

PMID: 39536026 PMC: 11559982. DOI: 10.1371/journal.pone.0313127.


Enhancing self-management of patients with inflammatory bowel disease: the role of autonomy support in health goal pursuit.

Horvat B, Orban K, David A, Sallay V, Rafael B, Njers S Therap Adv Gastroenterol. 2024; 17:17562848241275315.

PMID: 39290331 PMC: 11406597. DOI: 10.1177/17562848241275315.


Comprehensive Review of Chronic Stress Pathways and the Efficacy of Behavioral Stress Reduction Programs (BSRPs) in Managing Diseases.

Shchaslyvyi A, Antonenko S, Telegeev G Int J Environ Res Public Health. 2024; 21(8).

PMID: 39200687 PMC: 11353953. DOI: 10.3390/ijerph21081077.


Effects of an integrative multimodal inpatient program on fatigue and work ability in patients with Post-COVID Syndrome-a prospective observational study.

Schmid S, Uecker C, Frohlich A, Langhorst J Eur Arch Psychiatry Clin Neurosci. 2024; 274(8):1983-1991.

PMID: 38578435 DOI: 10.1007/s00406-024-01792-1.


Improving disease management of patients with inflammatory bowel disease: the potential role of self-concordant health goals.

Horvat B, David A, Sallay V, Rafael B, Njers S, Orban K Front Psychol. 2023; 14:1115160.

PMID: 37484082 PMC: 10359902. DOI: 10.3389/fpsyg.2023.1115160.


References
1.
Engler H, Elsenbruch S, Rebernik L, Kocke J, Cramer H, Schols M . Stress burden and neuroendocrine regulation of cytokine production in patients with ulcerative colitis in remission. Psychoneuroendocrinology. 2018; 98:101-107. DOI: 10.1016/j.psyneuen.2018.08.009. View

2.
Langhorst J, Anthonisen I, Steder-Neukamm U, Ludtke R, Spahn G, Michalsen A . Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey. Inflamm Bowel Dis. 2005; 11(3):287-95. DOI: 10.1097/01.mib.0000160771.71328.6c. View

3.
Joos S, Rosemann T, Szecsenyi J, Hahn E, Willich S, Brinkhaus B . Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease. BMC Complement Altern Med. 2006; 6:19. PMC: 1539021. DOI: 10.1186/1472-6882-6-19. View

4.
Hilsden R, Verhoef M, Rasmussen H, Porcino A, deBruyn J . Use of complementary and alternative medicine by patients with inflammatory bowel disease. Inflamm Bowel Dis. 2010; 17(2):655-62. DOI: 10.1002/ibd.21360. View

5.
Koch A, Schols M, Langhorst J, Dobos G, Cramer H . Perceived stress mediates the effect of yoga on quality of life and disease activity in ulcerative colitis. Secondary analysis of a randomized controlled trial. J Psychosom Res. 2020; 130:109917. DOI: 10.1016/j.jpsychores.2019.109917. View